AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 139 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,720 | -56.0% | 18,273 | -73.1% | 0.00% | – |
| Q1 2023 | $38,020 | +329.9% | 67,844 | +342.6% | 0.00% | – |
| Q4 2022 | $8,844 | -94.0% | 15,328 | -96.7% | 0.00% | – |
| Q3 2022 | $147,000 | +22.5% | 463,810 | +35.8% | 0.00% | – |
| Q2 2022 | $120,000 | -81.5% | 341,546 | -62.1% | 0.00% | – |
| Q1 2022 | $647,000 | -86.7% | 900,967 | -58.0% | 0.00% | -100.0% |
| Q4 2021 | $4,852,000 | +227.4% | 2,147,163 | +317.5% | 0.00% | – |
| Q3 2021 | $1,482,000 | -87.4% | 514,258 | -83.5% | 0.00% | -100.0% |
| Q2 2021 | $11,777,000 | +25.2% | 3,107,536 | +11.8% | 0.00% | +50.0% |
| Q1 2021 | $9,406,000 | -6.7% | 2,778,687 | -22.9% | 0.00% | -33.3% |
| Q4 2020 | $10,086,000 | +176.7% | 3,602,162 | +148.1% | 0.00% | +200.0% |
| Q3 2020 | $3,645,000 | -76.7% | 1,452,146 | +26.3% | 0.00% | -80.0% |
| Q2 2020 | $15,614,000 | +166.7% | 1,149,733 | +48.9% | 0.01% | +150.0% |
| Q1 2020 | $5,854,000 | +23.8% | 772,252 | +3.2% | 0.00% | +100.0% |
| Q4 2019 | $4,730,000 | +291.2% | 748,386 | +142.7% | 0.00% | – |
| Q3 2019 | $1,209,000 | -2.0% | 308,414 | +21.0% | 0.00% | – |
| Q2 2019 | $1,234,000 | -58.3% | 254,946 | -29.4% | 0.00% | -100.0% |
| Q1 2019 | $2,959,000 | +45.3% | 361,273 | -2.0% | 0.00% | 0.0% |
| Q4 2018 | $2,037,000 | +86.5% | 368,503 | +198.1% | 0.00% | – |
| Q3 2018 | $1,092,000 | -64.5% | 123,625 | -59.9% | 0.00% | -100.0% |
| Q2 2018 | $3,074,000 | -58.7% | 307,979 | -60.6% | 0.00% | -50.0% |
| Q1 2018 | $7,448,000 | -26.8% | 781,457 | +14.3% | 0.00% | 0.0% |
| Q4 2017 | $10,170,000 | -19.2% | 683,920 | +6.9% | 0.00% | -33.3% |
| Q3 2017 | $12,589,000 | +200.1% | 639,997 | +119.3% | 0.00% | +200.0% |
| Q2 2017 | $4,195,000 | +826.0% | 291,890 | +492.3% | 0.00% | – |
| Q1 2017 | $453,000 | -10.7% | 49,277 | +1.2% | 0.00% | – |
| Q4 2016 | $507,000 | +209.1% | 48,669 | +168.1% | 0.00% | – |
| Q3 2016 | $164,000 | +59.2% | 18,156 | +31.8% | 0.00% | – |
| Q2 2016 | $103,000 | -19.5% | 13,780 | -3.1% | 0.00% | – |
| Q1 2016 | $128,000 | -14.7% | 14,227 | +22.5% | 0.00% | – |
| Q4 2015 | $150,000 | -17.1% | 11,611 | -34.1% | 0.00% | – |
| Q2 2015 | $181,000 | – | 17,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |